Cargando…
Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
COPD patients prescribed inhaled corticosteroids (ICS) outside guidelines should be targeted for ICS withdrawal. Within a primary care population of 209,618 we used a combination of digital search algorithm, individual record review, and clinical review to identify COPD patients suitable for a trial...
Autores principales: | Harries, Timothy H, Gilworth, Gill, Corrigan, Christopher J, Murphy, Patrick B, Hart, Nicholas, Thomas, Mike, White, Patrick T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978678/ https://www.ncbi.nlm.nih.gov/pubmed/32021138 http://dx.doi.org/10.2147/COPD.S238239 |
Ejemplares similares
-
Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial
por: Harries, Timothy H, et al.
Publicado: (2022) -
Perceptions of COPD patients of the proposed withdrawal of inhaled
corticosteroids prescribed outside guidelines: A qualitative
study
por: Gilworth, Gill, et al.
Publicado: (2019) -
Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019) -
Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
por: Yawn, Barbara P, et al.
Publicado: (2016) -
Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
por: Cataldo, Didier, et al.
Publicado: (2018)